"Unlocking Success: Cell Based Assay Market Strategies 2022-2028"

The Cell Based Assay Market was estimated at US$ 19.3 billion in 2021 and is expected to grow at a CAGR of 6.86% during 2022-2028 to reach US$ 31.78 billion in 2028. In 2021, North America is expected to lead the cell-based assay market, driven by new drug introductions, technological advancements, and strategic collaborations enhancing drug discovery initiatives.